Factors involved in the absence of sedative effects by thesecond‐generation antihistamines
- 1 May 2000
- Vol. 55 (supp60) , 5-10
- https://doi.org/10.1034/j.1398-9995.2000.055supp60005.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor AntagonistJournal of Medicinal Chemistry, 1998
- Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7Experimental Neurology, 1996
- Modulation of Blood-Brain Barrier PermeabilityJournal of Drug Targeting, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- H1-Receptor AntagonistsDrug Safety, 1994
- Permeability of the blood-brain barrier to peptides: An approach to the development of therapeutically useful analogsPeptides, 1992
- Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonistsJournal of Medicinal Chemistry, 1988
- Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug DesignJournal of Pharmaceutical Sciences, 1987
- Histaminergic systems and sleepNeuropharmacology, 1985
- Are antihistamines sedative via a blockade of brain H1 receptors?Journal of Pharmacy and Pharmacology, 1979